How to buy Immunome shares | 11 March price $28.38

How to buy Immunome shares | $28.38

Own Immunome shares in just a few minutes. Share price changes are updated daily.

Immunome, Inc (IMNM) is a leading biotechnology business based in the US. It opened the day at $28.66 after a previous close of $28.54. During the day the price has varied from a low of $28.3 to a high of $29.52. The latest price was $28.38 (25 minute delay). Immunome is listed on the NASDAQ and employs 23 staff. All prices are listed in US Dollars.

How to buy shares in Immunome

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: IMNM in this case.
  5. Research Immunome shares. The platform should provide the latest information available.
  6. Buy your Immunome shares. It's that simple.
The whole process can take as little as 15 minutes.

Immunome share price

Use our graph to track the performance of IMNM stocks over time.

Immunome shares at a glance

Information last updated 2021-03-11.
Open$28.66
High$29.52
Low$28.3
Close$28.38
Previous close$28.54
Change $-0.16
Change % -0.5606%
Volume 26,347
Information last updated 2021-04-15.
52-week range$9.275 - $48.7
50-day moving average $32.5917
200-day moving average $18.9822
Wall St. target price$36
Dividend yield N/A (0%)
Earnings per share (TTM) N/A
Promoted
eToro Free Stocks

Invest in Immunome shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Fees for buying 20x Immunome shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Fineco logo £0 No minimum £6.98
£417.13 total
Capital at risk
eToro Free Stocks logo £0 $200 £2.05
£412.20 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.90
£411.05 total
Capital at risk
Stake logo £0 £50 £2.11
£412.26 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £16.11
£426.26 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £14.20
£424.35 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £14.68
£424.83 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Immunome stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Immunome price performance over time

Historical closes compared with the last close of $28.38

1 week (2021-04-13) -4.48%
1 month (2021-03-23) -19.24%

Financials

Gross profit TTM $0
Return on assets TTM -30.91%
Return on equity TTM -79.97%
Profit margin 0%
Market capitalisation $280.3 million

TTM: trailing 12 months

How to short and sell Immunome shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "IMNM.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 236,421 Immunome shares held short by investors – that's known as the "short interest". This figure is 20.9% up from 195,520 last month.

There are a few different ways that this level of interest in shorting Immunome shares can be evaluated.

Short interest ratio (SIR)

Immunome's "short interest ratio" (SIR) is the quantity of Immunome shares currently shorted divided by the average quantity of Immunome shares traded daily (recently around 85971.272727273). Immunome's SIR currently stands at 2.75. In other words for every 100,000 Immunome shares traded daily on the market, roughly 2750 shares are currently held short.

However Immunome's short interest can also be evaluated against the total number of Immunome shares, or, against the total number of tradable Immunome shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Immunome's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Immunome shares in existence, roughly 20 shares are currently held short) or 0.0293% of the tradable shares (for every 100,000 tradable Immunome shares, roughly 29 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Immunome.

Find out more about how you can short Immunome stock.

Immunome share dividends

We're not expecting Immunome to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

  • How to buy EQT shares | $19.04

    Ever wondered how to buy shares in EQT? We explain how and compare a range of providers that can give you access to many brands, including EQT.

  • How to buy Chesapeake Utilities shares | $117.675

    Ever wondered how to buy shares in Chesapeake Energy? We explain how and compare a range of providers that can give you access to many brands, including Chesapeake Energy.

  • How to buy Calyxt shares | $7.955

    Ever wondered how to buy shares in Calyxt? We explain how and compare a range of providers that can give you access to many brands, including Calyxt.

  • How to buy Brixmor Property Group shares | $20.68

    Ever wondered how to buy shares in Brixmor Property Group? We explain how and compare a range of providers that can give you access to many brands, including Brixmor Property Group.

  • How to buy Barnes Group shares | $56.25

    Ever wondered how to buy shares in Barnes Group? We explain how and compare a range of providers that can give you access to many brands, including Barnes Group.

  • How to buy AVROBIO shares | $13.2

    Ever wondered how to buy shares in AVROBIO? We explain how and compare a range of providers that can give you access to many brands, including AVROBIO.

  • How to buy Archrock shares | $10.51

    Ever wondered how to buy shares in Archrock? We explain how and compare a range of providers that can give you access to many brands, including Archrock.

  • How to buy Aeglea BioTherapeutics shares | $8.06

    Ever wondered how to buy shares in Aeglea BioTherapeutics? We explain how and compare a range of providers that can give you access to many brands, including Aeglea BioTherapeutics.

  • How to buy Advanced Disposal Services shares

    Ever wondered how to buy shares in Advanced Disposal Services? We explain how and compare a range of providers that can give you access to many brands, including Advanced Disposal Services.

  • How to buy Wyndham Hotels & Resorts shares | $68.355

    Ever wondered how to buy shares in Wyndham Hotels & Resorts? We explain how and compare a range of providers that can give you access to many brands, including Wyndham Hotels & Resorts.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site